TY - CHAP M1 - Book, Section TI - Stem Cells and Respiratory Disease: Prospects for the Future A1 - Alysandratos, Konstantinos-Dionysios A1 - Herriges, Michael J. A1 - Kotton, Darrell N. A2 - Grippi, Michael A. A2 - Antin-Ozerkis, Danielle E. A2 - Dela Cruz, Charles S. A2 - Kotloff, Robert M. A2 - Kotton, Camille Nelson A2 - Pack, Allan I. PY - 2023 T2 - Fishman’s Pulmonary Diseases and Disorders, 6e AB - Advances in stem cell research offer unprecedented opportunities to develop new treatments, disease models, and drug screens for previously untreatable conditions*. These discoveries have captivated the imagination of the lay press and have inspired hope in patients, clinicians, and scientists. Inevitably, in an emerging new field, there are false starts that accompany promising discoveries. If rigorous researchers in the field have difficulty discerning hype from hope, what is a busy clinician to do when confronted with basic questions, such as: “Is stem cell therapy available for my lung disease?” or “Shall I bank my baby’s cord blood in case he/she develops cystic fibrosis or emphysema?” This chapter is designed to describe the quickening pace of stem cell and regenerative medicine research related to lung disease and to place the latest discoveries in a historic context, before discussing future prospects. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/content.aspx?aid=1194945733 ER -